Science4Beauty raises EUR 1.6m from 4growth VC
Polish healthcare venture Science4Beauty has secured a EUR 1.6 million funding round backed by 4growth VC and Hard2beat. Terms, valuation, and use of proceeds were not disclosed.
Sector
Healthcare M&A
Healthcare M&A activity spans pharmaceuticals, biotechnology, medical devices, and healthcare services. The sector attracts both strategic consolidators seeking scale and private equity investors focused on platform building in specialized segments.
- Deals · 12mo
- 100
- Disclosed volume
- €8.1B
- Top investor
- Ada Ventures
- Top region
- EU
Latest news
Plastiflex buys Italy’s Sidam in strategic exit
Mindful Capital Partners and minority shareholder Berrier Capital have exited Italian single-use medical devices maker Sidam via a sale to Plastiflex Group, strengthening the buyer’s fluid-management platform.
Pharosyn raises EUR 2.5m for pharma intel
UK healthcare startup Pharosyn has secured EUR 2.5 million in funding to build a competitive-intelligence platform for pharmaceutical teams. Moonfire, Entrepreneurs First, Transpose Platform and General Advance participated.
Highland Europe leads EUR 40m Adaptyv Series A
Swiss AI-biotech Adaptyv Bio raised EUR 40 million in a Series A led by Highland Europe, with ACE Ventures, byFounders and Y Combinator participating. The round underscores Europe’s continued capital concentration into AI-native life-science platforms.
Radiology Partners to buy Everlight Radiology
Whistler Capital-backed Radiology Partners has agreed to acquire Everlight Radiology from Livingbridge, adding an established UK-led international teleradiology network to its platform. Terms were not disclosed.
Columna Capital exits Ardentis to Medbase
Columna Capital has exited Swiss dental platform Ardentis Cliniques Dentaires in an undisclosed transaction, selling a majority stake to Medbase. The deal extends consolidation momentum in French-speaking Switzerland’s dental market.
Mironid raises EUR 55.42m for rare kidney disease
UK healthcare company Mironid has secured EUR 55.42 million in funding from a syndicate including the Scottish National Investment Bank and Roche Venture Fund to advance a therapy for rare kidney disease.
Wise Equity takes control of Italy’s E-Pharma Trento
Wise Equity has announced a majority acquisition of E-Pharma Trento, an Italian CDMO with two Trento facilities. The deal underlines sustained PE appetite for outsourced pharma manufacturing, despite early reporting confusion on the target’s geography.
TA Associates drops Advanced Medical Solutions pursuit
TA Associates has ended its takeover interest in UK-listed Advanced Medical Solutions, pushing shares lower. Deal terms were never disclosed, leaving investors to reassess standalone prospects and optionality.
Alcolase raises EUR 1.5 million seed funding
Danish healthcare startup Alcolase has raised EUR 1.5 million in a funding round backed by Ada Ventures, Delphinus Venture Capital, Antler, Manigoff Invest and angel investors.
EQT and IDG advance in PolyPeptide auction
PolyPeptide Group has shortlisted EQT and IDG Capital as its sale process moves forward, according to Private Equity Wire. Financial terms have not been disclosed.
Alcolase raises EUR 1.5m for enzyme approach
Danish healthcare startup Alcolase has raised EUR 1.5 million from Ada Ventures, Delphinus Venture Capital, Antler, Manigoff Invest and business angels. The round backs development of an enzyme-based solution targeting alcohol intolerance.
HIG-backed Avanta Salud agrees to buy Vitaly Group
HIG Capital-backed Avanta Salud has agreed to acquire Spain-based Vitaly Group in an undisclosed transaction, adding scale in healthcare services.
Miura Partners buys Milan medical device distributor Medcomp
Miura Partners has acquired Italy-based Medcomp in an undisclosed deal, adding a Milan platform in medical device distribution. Deal terms and integration plans have not been disclosed.
Bain Capital acquires Italy’s Fabbrica Italiana Sintetici
Bain Capital Private Equity has agreed to acquire Fabbrica Italiana Sintetici (FIS), an Italian healthcare manufacturer. Financial terms were not disclosed.
Biophorum buys PharmaX Solutions under Five Arrows
Five Arrows-backed Biophorum has acquired UK-based PharmaX Solutions for an undisclosed amount. The deal extends Biophorum’s services footprint across the biopharma operating model.
Cytospire Therapeutics raises EUR 73.49m funding round
UK-based Cytospire Therapeutics has secured EUR 73.49 million in funding from a broad syndicate including 4BIO Capital, Servier Ventures and Abingworth to advance its oncology programme.
Benefit Street exits TFP Fertility to Amulet
Amulet Capital has agreed to acquire UK-based TFP Fertility Group from Benefit Street Partners. Financial terms were not disclosed.
Oura Health raises EUR 833.33 million in funding
Finnish healthtech Oura Health has announced a EUR 833.33 million funding round. The investor group and deal terms were not disclosed.
Baird Capital backs Blue Matter in undisclosed funding
Baird Capital has provided undisclosed funding to healthcare consulting firm Blue Matter. Deal terms and use of proceeds were not disclosed.